Evaluating the effects of daridorexant on sleep architecture
Gary Zammit, PhD, the President and CEO of Clinilabs Drug Development Corporation, has contributed to a scientific study evaluating the effect of daridorexant on sleep architecture in people with insomnia. The study examined the effects of daridorexant on hyperarousal-related features with results showing daridorexant reduced certain EEG features linked to hyperarousal. Daridorexant decreased the probability [...]